Abstract:Catechins are natural polyphenolic compounds with ability to minimize excess free radicals through different mechanisms including inhibition of NADPH oxidase (NOX) activity. NOX is a complex enzyme made-up of several subunits, where molecules including catechins binds to exert their effect. Hence, the attempt to probe the NOX enzyme’s binding subunit of catechins-induce effect. Several in-silico techniques were deployed in probing the NOX enzyme’s binding subunit of the catechins. The catechins were downloaded from PubChem database in SDF files. The five NOX subunits with PDB ID: 3A1F, 1OV3, 1HH4, 1OEY, and 7CFZ were downloaded from the protein databank. Drug-likeness properties and biological activities were predicted using ADMETMESH software. Catechin-NOX subunits’ interactions was performed via molecular docking, and the docked conformations were analyzed using Protein-plus software. The results of the study predicted the catechin compounds; epicatechin (E), epicatechin gallate (EG) and epigallocatehin gallate (EGG) are drug-like in nature and possess enzymes inhibitory properties. Docking result predicted catechins are capable of interacting with the various NADPH oxidase (NOX) subunits but in a varied degree. Their (catechins) strongest affinities was predicted on p40phox and p67phox PB1 subunit (PBD: 1OEY) with binding energies in the ranges of -8.3 to -9.9kcal/mol in this order; Apocynin>EGG>EG>E. While a weak affinity was predicted between the catechin compounds and gp91 (phox) subunit (PDB: 3A1F) with binding energies (-4.9 to -6.5 kcal/mol) in this sequence; E<apocynin<EGG<EG. In conclusion, the study predicted catechin compounds possess drug-likeness properties and has affinities for interaction with NADPH-oxidase subunits particularly the p40phox and p67phox PB1 probably to exert their antioxidant effects. Therefore, in vitro and in vivo study is recommended to verify this claim.

A Model of Interaction Between Nicotinamide Adenine Dinucleotide Phosphate (NADPH) Oxidase and Apocynin Analogues by Docking Method.

NADPH Oxidase Inhibition of Novel Apocynin Dimer Derivatives

Apocynin Attenuates Cerebral Infarction after Transient Focal Ischaemia in Rats

Synthesis of Novel Apocynin Dimer Derivatives

Investigation of NADPH-Oxidase’s Binding Subunit(s) for Catechin Compounds Induce Inhibition

Improvement Of Pharmacokinetics Behavior Of Apocynin By Nitrone Derivatization: Comparative Pharmacokinetics Of Nitrone-Apocynin And Its Parent Apocynin In Rats

In Silico Analysis of Antioxidant Phytochemicals with Potential NADPH Oxidase Inhibitory Effect

Combined Nadph And The Nox Inhibitor Apocynin Provides Greater Anti-Inflammatory And Neuroprotective Effects In A Mouse Model Of Stroke (Vol 104, Pg 333, 2017)

Combined NADPH and the NOX Inhibitor Apocynin Provides Greater Anti-Inflammatory and Neuroprotective Effects in a Mouse Model of Stroke

Interactions of SIRT1 with Acetyl Substrate, NAD+ or Nicotinamide

Pharmacology of apocynin: a natural acetophenone

Inhibition of NADPH oxidase alleviates experimental diabetes-induced myocardial contractile dysfunction.

NAD(P)H Oxidase Inhibiting with Apocynin Improved Vascular Reactivity in Tail-Suspended Hindlimb Unweighting Rat

Studies on the Synthesis of Nicotinamide Nucleoside and Nucleotide Analogues and Their Inhibitions Towards CD38 NADase

Molecular Simulations Bring New Insights into Protoporphyrinogen IX Oxidase/Protoporphyrinogen IX Interaction Modes

Insight into the structural requirements of protoporphyrinogen oxidase inhibitors: Molecular docking and CoMFA of diphenyl ether, isoxazole phenyl, and pyrazole phenyl ether

Synthesis and biological evaluations of novel apocynin analogues.

Synthesis and Biological Evaluation of Nicotinamide Adenine Dinucleotides Analogues As Inhibitors of Cd38

Design, Synthesis And Sar Studies Of Nad Analogues As Potent Inhibitors Towards Cd38 Nadase

Inhibitory mechanisms of apigenin and kaempfero towards human cytochrome P450 1A2

Induced-fit docking and virtual screening for 8-hydroxy-3-methoxy- 5H-pyrido [2,1-c] pyrazin-5-one derivatives as inducible nitric oxide synthase inhibitors